Seborrheic dermatitis: apply to affected area twice daily for 4 weeks or until clinical clearing. Reevaluate if no improvement after full course of treatment. Ketoconazole 2% cream is not for ...
Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...
GlobalData on MSN2mon
Health Canada approves Arcutis’ ZORYVE foam for seborrheic dermatitisThe US Food and Drug Administration (FDA) had previously approved ZORYVE foam 0.3% for seborrheic dermatitis in December 2023 ...
H.C. Wainwright analyst Douglas Tsao initiated coverage of Arcutis Biotherapeutics (ARQT) with a Buy rating and $19 price target The firm ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback